HCC is a highly heterogeneous cancer, and during last decade scientists clearly defined the landscape of genetic alterations in HCC, such as TERT, TP53 and CTNNB1 mutation, and amplification of VEGFA and FGF19/CCND14. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.